These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 39321115)

  • 1. A real-world study of persistence and adherence to prescription medications in patients with chronic idiopathic constipation in the United States.
    Cash BD; Lu M; Lembo A; Feuerstadt P; Nguyen L; Terasawa E; Ayyagari R; Du S; Pi S; Westermeyer B; Terreri B; Boules M; Moshiree B
    J Manag Care Spec Pharm; 2024 Oct; 30(10):1136-1148. PubMed ID: 39321115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis.
    Shah ED; Kim HM; Schoenfeld P
    Am J Gastroenterol; 2018 Mar; 113(3):329-338. PubMed ID: 29380823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New pharmacological treatment options for chronic constipation.
    Corsetti M; Tack J
    Expert Opin Pharmacother; 2014 May; 15(7):927-41. PubMed ID: 24661106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating When and Why Patients Discontinue Chronic Therapy for Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation.
    Shah ED; Suresh S; Jou J; Chey WD; Stidham RW
    Am J Gastroenterol; 2020 Apr; 115(4):596-602. PubMed ID: 32022721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
    Thomas RH; Luthin DR
    Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation.
    Chang L; Chey WD; Imdad A; Almario CV; Bharucha AE; Diem S; Greer KB; Hanson B; Harris LA; Ko C; Murad MH; Patel A; Shah ED; Lembo AJ; Sultan S
    Gastroenterology; 2023 Jun; 164(7):1086-1106. PubMed ID: 37211380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes Before and After Prucalopride Treatment: An Observational Study in Patients With Chronic Idiopathic Constipation in the United States.
    Lembo A; Cash BD; Lu M; Terasawa E; Terreri B; Du S; Ayyagari R; Feuerstadt P; Moshiree B; Westermeyer B; Pi S; Boules M
    Clin Transl Gastroenterol; 2024 May; 15(5):e00687. PubMed ID: 38357940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis.
    Ford AC; Suares NC
    Gut; 2011 Feb; 60(2):209-18. PubMed ID: 21205879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment paradigm and landscape for the management of chronic idiopathic constipation in adults: Focus on plecanatide.
    Martinez de Andino N
    J Am Assoc Nurse Pract; 2018 Jul; 30(7):412-420. PubMed ID: 29979299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation.
    Chang L; Chey WD; Imdad A; Almario CV; Bharucha AE; Diem S; Greer KB; Hanson B; Harris LA; Ko C; Murad MH; Patel A; Shah ED; Lembo AJ; Sultan S
    Am J Gastroenterol; 2023 Jun; 118(6):936-954. PubMed ID: 37204227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapies for constipation.
    Thayalasekeran S; Ali H; Tsai HH
    World J Gastroenterol; 2013 Dec; 19(45):8247-51. PubMed ID: 24363515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis.
    Luthra P; Camilleri M; Burr NE; Quigley EMM; Black CJ; Ford AC
    Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):831-844. PubMed ID: 31474542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plecanatide for the treatment of constipation-predominant irritable bowel syndrome.
    Miner PB
    Expert Rev Gastroenterol Hepatol; 2020 Feb; 14(2):71-84. PubMed ID: 31985305
    [No Abstract]   [Full Text] [Related]  

  • 14. Prucalopride (Motegrity) for chronic idiopathic constipation.
    Med Lett Drugs Ther; 2019 Jun; 61(1573):86-88. PubMed ID: 31170120
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluating the Impact of Cost on the Treatment Algorithm for Chronic Idiopathic Constipation: Cost-Effectiveness Analysis.
    Shah ED; Staller K; Nee J; Ahuja NK; Chan WW; Lembo A; Brenner DM; Siegel CA; Chey WD
    Am J Gastroenterol; 2021 Oct; 116(10):2118-2127. PubMed ID: 34388141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic Evaluation of Linaclotide for the Treatment of Adult Patients With Chronic Idiopathic Constipation in the United States.
    Huang H; Taylor DC; Carson RT; Sarocco P; Friedman M; Munsell M; Blum SI; Menzin J
    Manag Care; 2016 Feb; 25(2):41-8. PubMed ID: 27008836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacotherapy in Patients with Chronic Constipation].
    Kim SJ; Park KS
    Korean J Gastroenterol; 2017 Aug; 70(2):64-71. PubMed ID: 28830131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-World Treatment Strategies to Improve Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.
    Brenner DM; Harris LA; Chang CH; Waldman SA; Poppers DM; Kassebaum-Ladewski A; Sayuk GS
    Am J Gastroenterol; 2022 Apr; 117(4S):S21-S26. PubMed ID: 35354772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States.
    Nag A; Bornheimer R; Oster G
    Drugs Context; 2020; 9():. PubMed ID: 32863841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lubiprostone Is Effective in the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Li F; Fu T; Tong WD; Liu BH; Li CX; Gao Y; Wu JS; Wang XF; Zhang AP
    Mayo Clin Proc; 2016 Apr; 91(4):456-68. PubMed ID: 27046523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.